4.7 Article

Human Papillomavirus Prevalence Among American Indian Women of the Great Plains

Journal

JOURNAL OF INFECTIOUS DISEASES
Volume 219, Issue 6, Pages 908-915

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiy600

Keywords

human papillomavirus (HPV); human papillomavirus vaccination; American Indians; genotype distribution; self-sampling

Funding

  1. National Institutes of Health (NIH) National Cancer Institute [P50CA14811]
  2. Native Investigator Development Program through the NIH National Institute on Aging [P30AG015292]
  3. NIH National Institute of General Medical Sciences Institutional Research and Academic Career Development Award at the University of New Mexico [K12GM088021]
  4. Partnership for Native American Cancer Prevention (NIH National Cancer Institute) [U54CA143925]

Ask authors/readers for more resources

American Indian women are not sampled at a sufficient number in national studies to enable estimates of HPV prevalence. Herein, we report the largest study of HPV prevalence in American Indian women (n = 698) conducted to date.High-risk human papillomavirus (hrHPV) causes cervical cancer. In the United States, approximately 40% of women aged 1459 years from all racial and ethnic groups are infected with HPV, and prevalence typically declines with age. However, American Indian (AI) women are insufficiently sampled to permit a population-specific estimate of hrHPV prevalence. Vaginal swabs were self-collected by 698 AI women aged 2165 years from a tribal community in the Great Plains. We estimated the population prevalence of hrHPV and identified predominant genotypes. The combined prevalence of hrHPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 was 34.8%. HPV-51 (7.6%), HPV-58 (5.3%), HPV-52 (4.3%), HPV-18 (4.3%), and HPV-16 (3.9%) were most prevalent. hrHPV prevalence declined with age, from 42.2% in women aged 2124 years to 27.9% in women aged 5065 years. HPV-51 was the single most prevalent oncogenic genotype. The combined prevalence of hrHPV among AI women in our sample was high, particularly among women aged 5065 years, for whom hrHPV prevalence was approximately triple that of other races. Cervical cancer screening efforts should be increased, particularly among women from the community aged 30 years and older.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available